Drug recall · November 13, 2024
Ascorbic Acid Inj. Solution recall
Why: Presence of Particulate Matter: Presence of glass particulates.
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
Ascorbic Acid Inj. Solution, 25,000mg/50mL (500mg/mL), 50mL single use vial, Rx only, Staska Pharmaceuticals, 742 Evergreen Drive, Bennet, NE 68317
- Lots / codes
Lot #SP2400058, Exp 12/31/2024
- Quantity
- 4773 vials
- Company
- Staska Pharmaceuticals, Inc., Bennet, NE
- Distribution
- Nationwide in the USA
- Initiated
- September 30, 2024 · Voluntary: Firm initiated
- Classified
- November 7, 2024
- Reported
- November 13, 2024
- Ended
- August 5, 2025
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Ascorbic acid
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.